Product Information
PREGABALIN 20 MG/ML SOLUTION is a generic product labeled by Patrin Pharma Inc., priced at $0.1530 per ML under NDC 39328009016. Its NADAC has been published 177 times since May 17, 2023.
FDA first approved this application on Feb 18, 2022. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/mL
Manufacturer
Patrin Pharma Inc.NDC
39328009016
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA212604FDA Approved
2/18/2022
TE Code
AA
On Market Since
6/14/2022
Price Statistics
The NADAC for PREGABALIN 20 MG/ML SOLUTION has been published 177 times since May 17, 2023, and over the history we have for it it has risen 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1530 per ML |
|---|---|
| All-time high | $0.1660 (Mar 11, 2026) |
| All-time low | $0.1052 (Sep 20, 2023) |
| 52-week high | $0.1660 |
| 52-week low | $0.1505 |
| Median price | $0.1418 |
| Average price | $0.1365 |
| Largest weekly change | +27.3% (Apr 17, 2024) |
| Weeks tracked | 177 |
| Tracking since | May 17, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PREGABALIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Patrin Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PREGABALIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 20 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 20 MG/ML SOLUTION, manufactured by Patrin Pharma Inc., is $0.1530 per ML (NDC 39328009016), effective Sep 30, 2026.
How has the price of PREGABALIN 20 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for PREGABALIN 20 MG/ML SOLUTION has risen 27.6%. It has been tracked across 177 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for PREGABALIN 20 MG/ML SOLUTION?
Since May 17, 2023, the NADAC for PREGABALIN 20 MG/ML SOLUTION has ranged from a low of $0.1052 (Sep 20, 2023) to a high of $0.1660 (Mar 11, 2026), with a median of $0.1418 per ML.
Are there cheaper alternatives to PREGABALIN 20 MG/ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of PREGABALIN 20 MG/ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PREGABALIN 20 MG/ML SOLUTION?
PREGABALIN 20 MG/ML SOLUTION (NDC 39328009016) is labeled by Patrin Pharma Inc., and CMS classifies it as a generic product.